# A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium

> **NCT06677892** · — · RECRUITING · sponsor: **Takeda** · enrollment: 75 (estimated)

## Conditions studied

- Cytomegalovirus (CMV)

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT06677892
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-24
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06677892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06677892, "A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06677892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*